Primorigen Biosciences has been acquired by Nucleus Biologics, a leader in precision cell culture, the company announced today. “The exceptionally strong fit of the Nucleus and Primorigen product portfolios provide…
Exact Sciences will acquire Genomic Health, a provider of genomic-based diagnostic tests that help optimize cancer care, in a cash and stock transaction valued at $2.8 billion, the company announced today. According to…
NorthStar Medical Radioisotopes has been awarded $15 million in a cooperative agreement with the U.S. Department of Energy’s National Nuclear Security Administration (DOE/NNSA), the company announced today. According to a…
SHINE Medical Technologies has filed an application with the U.S. Nuclear Regulatory Commission to produce medical isotopes at its production facility in Janesville, Wis., the company announced today. “Completing our…
FUJIFILM Cellular Dynamics and Axcelead Drug Discovery Partners are collaborating to provide customers with a human induced pluripotent stem cell (iPSC)-based integrated platform for drug discovery solutions, the company announced recently….
Exact Sciences opened its new 169,000-square foot clinical lab on the west side of Madison this week, the company announced recently. “Madison, Wisconsin is the home of earlier cancer detection,”…
SHINE and Phoenix have completed a 132-hour test of the high-flux Phoenix neutron generator that helps to prove the performance and reliability of Phoenix’s neutron generator technology and SHINE’s medical isotope production process, the companies…
Propeller Health and the Cleveland Clinic have partnered on a COPD study, the company announced today. According to a release, research using Propeller’s platform shows that digital medicines reduced hospital visits…
Promega has partnered with BioIVT, a provider of research models and services for drug and diagnostic development, the company announced today. According to a release, BioIVT will offer Promega Immune…
Exact Sciences, along with the Mayo Clinic, reports that early research using blood-based methylated DNA markers demonstrate a potential to achieve 92% sensitivity and 92% specificity for detecting the most…
